1082 related articles for article (PubMed ID: 19445928)
1. Protective effect of rivastigmine against 3-nitropropionic acid-induced Huntington's disease like symptoms: possible behavioural, biochemical and cellular alterations.
Kumar P; Kumar A
Eur J Pharmacol; 2009 Aug; 615(1-3):91-101. PubMed ID: 19445928
[TBL] [Abstract][Full Text] [Related]
2. Tiagabine, a GABA uptake inhibitor, attenuates 3-nitropropionic acid-induced alterations in various behavioral and biochemical parameters in rats.
Dhir A; Akula KK; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):835-43. PubMed ID: 18234412
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of hesperidin and naringin against 3-nitropropionic acid induced Huntington's like symptoms in rats: possible role of nitric oxide.
Kumar P; Kumar A
Behav Brain Res; 2010 Jan; 206(1):38-46. PubMed ID: 19716383
[TBL] [Abstract][Full Text] [Related]
4. Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain.
Kumar P; Kumar A
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):100-8. PubMed ID: 19022325
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations.
Binawade Y; Jagtap A
J Med Food; 2013 Oct; 16(10):934-43. PubMed ID: 24138168
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats: possible neuroprotective mechanisms.
Bhateja DK; Dhull DK; Gill A; Sidhu A; Sharma S; Reddy BV; Padi SS
Eur J Pharmacol; 2012 Jan; 674(1):33-43. PubMed ID: 22056833
[TBL] [Abstract][Full Text] [Related]
7. Protective role of sertraline against 3-nitropropionic acid-induced cognitive dysfunction and redox ratio in striatum, cortex and hippocampus of rat brain.
Kumar P; Kumar A
Indian J Exp Biol; 2009 Sep; 47(9):715-22. PubMed ID: 19957883
[TBL] [Abstract][Full Text] [Related]
8. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease.
Kumar P; Kumar A
J Med Food; 2009 Jun; 12(3):591-600. PubMed ID: 19627208
[TBL] [Abstract][Full Text] [Related]
9. Cyclosporine A attenuates 3-nitropropionic acid-induced Huntington-like symptoms in rats: possible nitric oxide mechanism.
Kumar P; Kalonia H; Kumar A
Int J Toxicol; 2010; 29(3):318-25. PubMed ID: 20448265
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of naringin against ischemic reperfusion cerebral injury: possible neurobehavioral, biochemical and cellular alterations in rat brain.
Gaur V; Aggarwal A; Kumar A
Eur J Pharmacol; 2009 Aug; 616(1-3):147-54. PubMed ID: 19577560
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effect of MK-801 against intra-striatal quinolinic acid induced behavioral, oxidative stress and cellular alterations in rats.
Kalonia H; Kumar P; Nehru B; Kumar A
Indian J Exp Biol; 2009 Nov; 47(11):880-92. PubMed ID: 20099461
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms.
Kumar P; Padi SS; Naidu PS; Kumar A
Fundam Clin Pharmacol; 2007 Jun; 21(3):297-306. PubMed ID: 17521299
[TBL] [Abstract][Full Text] [Related]
13. Sesamol attenuate 3-nitropropionic acid-induced Huntington-like behavioral, biochemical, and cellular alterations in rats.
Kumar P; Kalonia H; Kumar A
J Asian Nat Prod Res; 2009; 11(5):439-50. PubMed ID: 19504387
[TBL] [Abstract][Full Text] [Related]
14. Potential of protease inhibitor in 3-nitropropionic acid induced Huntington's disease like symptoms: mitochondrial dysfunction and neurodegeneration.
Hariharan A; Shetty S; Shirole T; Jagtap AG
Neurotoxicology; 2014 Dec; 45():139-48. PubMed ID: 25445565
[TBL] [Abstract][Full Text] [Related]
15. Licofelone attenuates quinolinic acid induced Huntington like symptoms: possible behavioral, biochemical and cellular alterations.
Kalonia H; Kumar P; Kumar A
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):607-15. PubMed ID: 21237233
[TBL] [Abstract][Full Text] [Related]
16. Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease.
Kalonia H; Kumar P; Kumar A
Pharmacol Biochem Behav; 2010 Aug; 96(2):115-24. PubMed ID: 20450929
[TBL] [Abstract][Full Text] [Related]
17. Possible GABAergic mechanism in the neuroprotective effect of gabapentin and lamotrigine against 3-nitropropionic acid induced neurotoxicity.
Kumar P; Kalonia H; Kumar A
Eur J Pharmacol; 2012 Jan; 674(2-3):265-74. PubMed ID: 22154757
[TBL] [Abstract][Full Text] [Related]
18. Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism.
Kumar P; Kumar A
Food Chem Toxicol; 2009 Oct; 47(10):2522-30. PubMed ID: 19616597
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease.
Túnez I; Montilla P; Del Carmen Muñoz M; Feijóo M; Salcedo M
J Pineal Res; 2004 Nov; 37(4):252-6. PubMed ID: 15485551
[TBL] [Abstract][Full Text] [Related]
20. Role of neurosteroids in experimental 3-nitropropionic acid induced neurotoxicity in rats.
Kumar P; Kumar P; Khan A; Deshmukh R; Lal Sharma P
Eur J Pharmacol; 2014 Jan; 723():38-45. PubMed ID: 24333475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
